Related Experiment Video
Updated: Aug 2, 2026

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Advances and challenges in neuropathic pain: a narrative review and future directions
Nadine Attal1, Didier Bouhassira1, Lesley Colvin2
1Inserm U987, UVSQ-Paris-Saclay University, Ambroise Pare Hospital, Boulogne-Billancourt, France.
Abstract:
Over the past few decades, substantial advances have been made in neuropathic pain clinical research. An updated definition and classification have been agreed. Validated questionnaires have improved the detection and assessment of acute and chronic neuropathic pain; and newer neuropathic pain syndromes associated with COVID-19 have been described. The management of neuropathic pain has moved from empirical to evidence-based medicine. However, appropriately targeting current medications and the successful clinical development of drugs acting on new targets remain challenging. Innovative approaches to improving therapeutic strategies are required. These mainly encompass rational combination therapy, drug repurposing, non-pharmacological approaches (such as neurostimulation techniques), and personalised therapeutic management. This narrative review reports historical and current perspectives regarding the definitions, classification, assessment, and management of neuropathic pain and explores potential avenues for future research.
More Related Videos
Related Concept Videos
Nociception
Analgesia and Pain Management
Pain

